Zevalin Radioimmunotherapy is Not Associated with an Increased Incidence of Secondary Myelodysplastic Syndrome (MDS) or Acute Myelogenous Leukemia (AML)

Reviewer: Ryan Smith, MD
OncoLink
Ultima Vez Modificado: 7 de diciembre del 2002

Translation for this article does not exist

Blogs

The Power of a Cancer Support Group
by Bob Riter
May 26, 2016